SCHEMBL217476

SCHEMBL217476

CC(CO)(CO)C(=O)[O-].CC(CO)(CO)C(=O)[O-].CC(CO)(CO)C(=O)[O-].[Bi+3]

nearest known ligand 0.33

Known targets — ChEMBL curated mechanism

HRH2

The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.32
TSHR P16473 1/20 0.32
CYP2C19 P33261 1/20 0.32
HIF1A Q16665 1/20 0.32
CA2 P00918 1/20 0.32
CA1 P00915 2/20 0.32
PRKCA P17252 1/20 0.31
CA4 P22748 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Zinc Ion SCHEMBL5144410 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
SCHEMBL5144808 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
SCHEMBL2031599 0.94 CA2 (0.38) CYP2D6TSHRCYP2C19HIF1ACA2
SCHEMBL5144685 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
SCHEMBL5080076 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
SCHEMBL5080079 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
Lithium Ion SCHEMBL5144788 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
SCHEMBL5165796 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
SCHEMBL5142314 0.94 CYP2D6 (0.32) CYP2D6TSHRCYP2C19HIF1ACA2
Potassium Ion SCHEMBL2701663 0.94 CA4 (0.35) CYP2D6TSHRCYP2C19HIF1ACA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 157 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8815066-B2 Coating composition with phosphorous-containing resins and organometallic compounds BASF COATINGS GMBH (DE) 2014-08-26 US claimed
EP-1587886-B1 CATHODIC ELECTRODEPOSITION COATING COMPOSITIONS CONTAINING BISMUTH COMPOUNDS AND DICARBOXYLIC ACIDS, PRODUCTION AND USE THEREOF DU PONT (US) 2009-07-29 EP claimed
US-7374650-B2 Cathodic electrodeposition coating agents containing bismuth salts together with yttrium and/or neodymium compounds, production and use thereof E.I. DU PONT DE NEMOURS & COMPANY (US) 2008-05-20 US claimed
US-7351319-B2 Cathodic electrodeposition coating compositions containing bismuth compounds and dicarboxylic acids, production and use thereof E. I. DU PONT DE NEMOURS & CO. (US) 2008-04-01 US claimed
EP-1384760-B1 Cathodic electrodeposition coating agents containing bismuth salts together with yttrium and/or neodymium compounds, production and use thereof DU PONT (US) 2007-02-28 EP claimed
EP-1587886-A1 CATHODIC ELECTRODEPOSITION COATING COMPOSITIONS CONTAINING BISMUTH COMPOUNDS AND DICARBOXYLIC ACIDS, PRODUCTION AND USE THEREOF E.I. du Pont de Nemours and Company (US) 2005-10-26 EP claimed
WO-2004067651-A1 CATHODIC ELECTRODEPOSITION COATING COMPOSITIONS CONTAINING BISMUTH COMPOUNDS AND DICARBOXYLIC ACIDS, PRODUCTION AND USE THEREOF E.I. DU PONT DE NEMOURS AND COMPANY (US) 2004-08-12 WO claimed
US-20040146716-A1 Cathodic electrodeposition coating compositions containing bismuth compounds and dicarboxylic acids, production and use thereof E. I. DU PONT DE NEMOURS AND COMPANY 2004-07-29 US claimed
US-20040106710-A1 Cathodic electrodeposition coating agents containing bismuth salts together with yttrium and/or neodymium compounds, production and use thereof E. I. DU PONT DE NEMOURS AND COMPANY 2004-06-03 US claimed
EP-1384760-A1 Cathodic electrodeposition coating agents containing bismuth salts together with yttrium and/or neodymium compounds, production and use thereof E.I. DUPONT DE NEMOURS AND COMPANY (US) 2004-01-28 EP claimed
EP-0783548-B2 PROCESS FOR PRODUCING A COATING WHICH PROTECTS AGAINST CORROSION AND HAS GOOD ADHESION, AND THE WORKPIECES THUS OBTAINED DU PONT (US) 2001-11-28 EP claimed
EP-0739389-B1 SIMPLIFIED PROCESS FOR PRODUCING AN ANTICORROSIVE PAINT WITH A GOOD ADHESIVENESS AND WORKPIECES THUS OBTAINED HERBERTS & CO GMBH (DE) 1998-05-20 EP claimed
EP-0783548-B1 PROCESS FOR PRODUCING A COATING WHICH PROTECTS AGAINST CORROSION AND HAS GOOD ADHESION, AND THE WORKPIECES THUS OBTAINED HERBERTS & CO GMBH (DE) 1998-04-08 EP claimed
US-5702581-A PRETREATING METAL SUBSTRATE TO PHOSPHATE TREATMENT, CARRYING OUT ELECTROPHORETIC DIP LACQUER COATING CONTAINING BISMUTH SALT HERBERTS GMBH (DE) 1997-12-30 US claimed
EP-4720205-A1 ELECTRODEPOSITABLE COATING COMPOSITIONS COMPRISING CALCINED CLAY PPG Industries Ohio Inc. (US) 2026-04-08 EP disclosed
US-20260042919-A1 ELECTRODEPOSITABLE COATING COMPOSITIONS PPG INDUSTRIES OHIO, INC. (US) 2026-02-12 US disclosed
US-12344762-B2 Phosphate resistant electrodepositable coating compositions PPG INDUSTRIES OHIO, INC. (US) 2025-07-01 US disclosed
US-5554700-A BISMUTH SALT OF ALIPHATIC HYDROXYCARBOXYLIC ACID VIANOVA RESINS AG (AT) 1996-09-10 US disclosed
US-5507928-A POWDER COATING ONTO AN ELECTRODEPOSITED AQUEOUS COATINGS, LOW TEMPERATURE BAKING TO FAST CROSSLINKING HERBERTS GMBH (DE) 1996-04-16 US disclosed
WO-1996010057-A1 PROCESS FOR PRODUCING A COATING WHICH PROTECTS AGAINST CORROSION AND HAS GOOD ADHESION, AND THE WORKPIECES THUS OBTAINED Herberts Gesellschaft mit beschränkter Haftung (DE) 1996-04-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260042919-A1 ELECTRODEPOSITABLE COATING COMPOSITIONS SLC6A1, PUF60, SLC6A11 CYP2D6 4692/4885TSHR 4498/4885CYP2C19 3886/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.